MB and neoplasm: Further support for considering Mb as a diagnostic marker of the luminal breast cancer subtype comes from the in silico analysis of Farmer et al's data, in which Mb transcript levels were highest in tumours classified as the luminal subtype (Farmer et al, 2005).